Ondexxya
(Remimazolam Besylate)ApprovedSmall molecule
Remimazolam is used to put patients to sleep quickly during medical procedures and surgeries. It works fast and wears off quickly, making it useful for short procedures where doctors need patients unconscious for a brief time.[2] Ondexxya is currently approved and in use across 6 indications[4].[1]
Ondexxya is one of 155 small molecule programs targeting Arrhythmia. It is currently in Approved.
6
Indications
32
Total Trials
8
Active Trials
154
Competitors
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
476 competitors in Kidney Transplant
#DrugCompanyPhaseTrials
1Ondexxya
UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Approved
Nulojix
Bristol-Myers SquibbPreclinical
Simulect
NovartisPreclinical
Medrol
PfizerPreclinical
Zemplar
AbbViePreclinical
Cysteine Hydrochloride
NovartisPreclinical
Epogen
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Preclinical
Radicava
ShionogiPreclinical
Jardiance
Boehringer IngelheimPreclinical
Nydrazid
KKaruna Therapeutics, Inc., a Bristol Myers Squibb company
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sedation10 trials
A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy
Recruiting·—·Phase 4·NCT07456111·90 enrolled
Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients
Recruiting·—·Phase 4·NCT06575530·306 enrolled
Show 7 more trials
The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate
Not yet recruiting·—··NCT06427785·30 enrolled
REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults
Not yet recruiting·—·Phase 3·NCT07155265·180 enrolled
Long-term Sedation With Remimazolam Besylate in Critically Ill Patients
Unknown status·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 3·NCT05555667·728 enrolled
Remimazolam7 trials
Remimazolam Besylate3 trials
The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia
Not yet recruiting·—·Phase 1·NCT06717945·320 enrolled
The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction
Completed·SSecond Affiliated Hospital of Wenzhou Medical University·Phase 4·NCT06061159·120 enrolled
Atrial Fibrillation1 trial
Impaired Renal Function1 trial
10 more indications
Total Intravenous Anesthesia1 trial
Hemodynamic Stability1 trial
Nausea and vomiting1 trial
Treatment1 trial
Elderly Patients1 trial
Postoperative Quality of Recovery1 trial
Postoperative Quality of Recovery After General Anesthesia With Remimazolam
Unknown status·—·N/A·NCT06332157·126 enrolled
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Ondexxya drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Remimazolam Besylate. EMBL-EBI & Wellcome Sanger Institute.
- [5]
Details